0
0
7/8/23 at 4:32pm
Organization
The Times of Israel
37 words
0
Comments
Leqembi is first medicine convincingly shown to modestly slow cognitive decline, but some experts say effect too subtle, note dangers
You are the first to view
https://www.timesofisrael.com/novel-alzheimers-drug-gets-full-fda-approval-though-efficacy-and-risk-questioned/
Create an account
or login to join the discussion